Hemostatic therapy should be used for acute treatment of anticoagulation-related intracerebral hemorrhage.
FAHA, Washington University School of Medicine, Department of Neurology, Campus Box 8111, 660 S Euclid Avenue, St Louis, MO 63110, USA. diringerm@neuro.wustl.edu
Michael N
MN
Diringer
Allyson R
AR
Zazulia
D055371:Acute Lung Injury / Q000209:etiology / Q000628:therapy; D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000628:therapy*; D005167:Factor VII / Q000627:therapeutic use; D005260:Female; D006350:Heart Valve Prosthesis; D006489:Hemostatic Techniques / Q000009:adverse effects*; D006490:Hemostatics / Q000009:adverse effects*; D006801:Humans; D019934:International Normalized Ratio; D010949:Plasma; D011516:Prothrombin / Q000627:therapeutic use; D065227:Transfusion Reaction; D014859:Warfarin / Q000009:adverse effects / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D006490:Hemostatics; D014859:Warfarin; D005167:Factor VII; D011516:Prothrombin